Outcomes-based Contracts on the Rise

from tHEORetically Speaking: The HealthEconomics.Com Blog at http://bit.ly/2qCaRCu on May 31, 2017 at 04:18PM A new Avalere report surveyed United States health plans and shows around 30 percent currently negotiating one or more outcomes-based contracts. This report breaks everything down by specialty. See more here. (Source: Laura Dyrda, Becker’s ASCReview, 5/30/17)

After-hours GP home visits strain the budget (and don’t help emergency departments)

from The Conversation – health economics at http://bit.ly/2rcpcs8 on May 31, 2017 at 02:42PM After-hours home medical services are offered with bulk billing. But are they the best use of taxpayers’ money? from http://www.shutterstock.com After-hours home medical services are a burden on our health budget and don’t ease the strain on emergency departments after all, […]

Former FDA Commissioner on the FDA and RWE

from tHEORetically Speaking: The HealthEconomics.Com Blog at http://bit.ly/2rqg3MR on May 31, 2017 at 02:17PM Former FDA Commissioner, Robert Califf, MD, was recently interviewed ahead of the upcoming Data, Evidence and Access Summit 2017, on his views on the prevalence of real world evidence (RWE) and the Food and Drug Administration (FDA)’s acceptance of it. Find […]

Telomere Length and Neighborhood Circumstances

from RAND Research Topic: Health and Health Care at http://bit.ly/2rl5oRt on May 31, 2017 at 01:18PM Background Multilevel frameworks suggest neighborhood circumstances influence biology; however, this relationship is not well studied. Telomere length (TL) shortening has been associated with individual-level and neighborhood-level exposures and disease and may provide insights into underlying biologic mechanisms linking neighborhood […]

Racial/ethnic Differences in Perception of Need for Mental Health Treatment in a US National Sample

from RAND Research Topic: Health and Health Care at http://bit.ly/2qBKQHz on May 31, 2017 at 01:18PM Purpose To resolve contradictory evidence regarding racial/ethnic differences in perceived need for mental health treatment in the USA using a large and diverse epidemiologic sample. Methods Samples from 6 years of a repeated cross-sectional survey of the US civilian […]

Valuing EQ-5D-5L health states ‘in context’ using a discrete choice experiment

from The European Journal of Health Economics at http://bit.ly/2qB92Kc on May 31, 2017 at 01:03PM Abstract Background In health state valuation studies, health states are typically presented as a series of sentences, each describing a health dimension and severity ‘level’. Differences in the severity levels can be subtle, and confusion about which is ‘worse’ can […]

Valuing EQ-5D-5L health states ‘in context’ using a discrete choice experiment

from The European Journal of Health Economics at http://bit.ly/2qB92Kc on May 31, 2017 at 11:12AM Abstract Background In health state valuation studies, health states are typically presented as a series of sentences, each describing a health dimension and severity ‘level’. Differences in the severity levels can be subtle, and confusion about which is ‘worse’ can […]

Innovating for Answers

from RAND Research Topic: Health and Health Care at http://bit.ly/2rEoJ3k on May 31, 2017 at 07:16AM For nearly 60 years, the RAND Corporation has broken new ground in confronting some of society’s most complex problems — all with the goals of improving public health, educational achievement, economic performance, environmental well-being, and public safety in the […]

Eliciting the Monetary Value of a Quality-Adjusted Life Year in a Greek Outpatient Department in Times of Economic Austerity

from PharmacoEconomics – Open at http://bit.ly/2rjLM0o on May 31, 2017 at 07:09AM Abstract Background and objective Contingent valuation is widely used to determine individuals’ willingness to pay (WTP) for a health gain. Our study aimed to elicit an empirical estimate of the monetary value of a quality-adjusted life year (QALY) in a Greek outpatient setting […]

Cost-effectiveness of posaconazole tablets versus fluconazole as prophylaxis for invasive fungal diseases in patients with graft-versus-host disease after allogeneic hematopoietic stem cell transplantation

from The European Journal of Health Economics at http://bit.ly/2rDTIfR on May 31, 2017 at 05:03AM Abstract Background The cost-effectiveness of posaconazole oral suspension versus fluconazole capsules for the prophylaxis of invasive fungal diseases (IFDs) in immunosuppressed allogeneic hematopoietic stem cell transplantation (HSCT) recipients has already been proven. Now, a new solid oral tablet formulation for […]

Cost-effectiveness of posaconazole tablets versus fluconazole as prophylaxis for invasive fungal diseases in patients with graft-versus-host disease after allogeneic hematopoietic stem cell transplantation

from The European Journal of Health Economics at http://bit.ly/2rDTIfR on May 31, 2017 at 02:42AM Abstract Background The cost-effectiveness of posaconazole oral suspension versus fluconazole capsules for the prophylaxis of invasive fungal diseases (IFDs) in immunosuppressed allogeneic hematopoietic stem cell transplantation (HSCT) recipients has already been proven. Now, a new solid oral tablet formulation for […]

Controversies on QALYs

from Econsalut at http://bit.ly/2scOGUq on May 31, 2017 at 02:19AM The Limitations of QALY: A Literature Review After 50 years, valuing health using QALYs is still a daunting task. Basically the debate over ethical considerations, methodological issues and… [[ This is a content summary only. Visit my website for full links, other content, and more! […]

Predicting Real-World Effectiveness of Cancer Therapies Using OS and PFS Clinical Trials Endpoints

from Healthcare Economist at http://bit.ly/2rigqqF on May 30, 2017 at 09:12PM Clinical trials for cancer treatments aim to demonstrate whether one treatment is better than another. What is of most interest to patients, providers and payers, however, is which treatment works best in the real-world, not in a randomized controlled trial. Further, clinical trials often […]

Family Perspectives on Telemedicine for Pediatric Subspecialty Care

from RAND Research Topic: Health and Health Care at http://bit.ly/2qxykbW on May 30, 2017 at 06:19PM Background Children often have difficulty accessing subspecialty care, and telemedicine may improve access to subspecialty care, but information is lacking on how best to implement telemedicine programs to maximize acceptance and, ultimately, maximize impact for patients and their families. […]

Winning the Doctor Lottery

from THCB at http://bit.ly/2rhLsz4 on May 30, 2017 at 04:14PM By ANISH KOKA, MD A poignant piece recently appeared in the journal Health Affairs and was rapidly devoured on social media by the health policy community. The story is a harrowing first person account of a woman’s multiple interactions with doctors. The doctors in the […]

Beyond Medication Reconciliation

from RAND Research Topic: Health and Health Care at http://bit.ly/2rleCz9 on May 30, 2017 at 03:14PM Medication reconciliation is a major focus of quality measurement activities, and according to The Joint Commission, primary care clinicians are expected to reconcile a patient’s medications at every visit. In principle, medication reconciliation is quite important; in practice, however, […]

Reaching Concerned Partners of Heavy Drinking Service Members and Veterans Through Facebook

from RAND Research Topic: Health and Health Care at http://bit.ly/2rhcOVU on May 30, 2017 at 02:17PM Military populations are hard to reach for alcohol interventions. The authors used a Facebook ad campaign to successfully recruit military spouses who were concerned about their service member or veteran partner’s drinking behaviors. In 90 days, the authors recruited […]

Partnering to Improve Care

from RAND Research Topic: Health and Health Care at http://bit.ly/2qwSiDE on May 30, 2017 at 02:17PM Background Within many large health care organizations, researchers and operations partners (i.e., policymakers, managers, clinical leaders) join to conduct studies to improve the quality of patient care. Yet optimal approaches to conducting partnership research and evaluation are only beginning […]

Simulation Modelling in Healthcare: An Umbrella Review of Systematic Literature Reviews

from PharmacoEconomics at http://bit.ly/2saZcf5 on May 30, 2017 at 12:42PM Abstract Background Numerous studies examine simulation modelling in healthcare. These studies present a bewildering array of simulation techniques and applications, making it challenging to characterise the literature. Objective The aim of this paper is to provide an overview of the level of activity of simulation […]

A Randomized Controlled Trial of Rise, a Community-Based Culturally Congruent Adherence Intervention for Black Americans Living with HIV

from RAND Research Topic: Health and Health Care at http://bit.ly/2r89huB on May 30, 2017 at 11:14AM Evidence-based HIV treatment adherence interventions have typically shown medium-sized effects on adherence. Prior evidence-based HIV treatment adherence interventions have not been culturally adapted specifically for Black/African Americans, the population most affected by HIV disparities in the USA, who exhibit […]

LGBTQ Students More Likely to Seek Mental Health Services When Needed, but Still Face Barriers to Using Campus Services

from RAND Research Topic: Health and Health Care at http://bit.ly/2r86EJv on May 30, 2017 at 11:14AM FOR RELEASE TuesdayMay 30, 2017 College students who belong to sexual minority groups are more likely to seek help for mental health problems than their straight peers, but they still face many barriers to using on-campus mental health services, […]

How does the influence of time horizon impact the results of cost-effectiveness analyses?

from CEA Registry Team at http://bit.ly/2saBX4G on May 30, 2017 at 11:14AM A new study recently posted in Expert Review of Pharmacoeconomics & Outcomes Research, addresses the gap of knowledge between assumed time horizons across CEAs, and the relationship between the time horizons and estimated costs, benefits, and cost-effectiveness.   Among 782 articles identified from […]

Market power matters

from The Incidental Economist at http://bit.ly/2rBogi2 on May 30, 2017 at 10:24AM It’s the clash of titans. In January the Massachusetts the Group Insurance Commission (GIC) — the state agency that provides health insurance to nearly a half-million public employees, retirees, and their families — voted to cap provider payments at 160% of Medicare rates. […]

Evidera – Looking for a Medical Writer

from tHEORetically Speaking: The HealthEconomics.Com Blog at http://bit.ly/2sagkSd on May 30, 2017 at 09:38AM Evidera is looking to fill a position in Medical Writing and Communications. Location may be based on your experience and qualifications! Find out more about this job posting and many others in this week’s HealthEconomics.Com Jobs Newsletter, your connection to the […]

Assessing the Value of New Antibiotics: Additional Elements of Value for Health Technology Assessment Decisions

from News at http://bit.ly/2qCmKr5 on May 30, 2017 at 08:26AM Antimicrobial resistance (AMR) occurs when microorganisms such as bacteria, viruses, fungi and parasites change in ways that render the medications used to cure the infections they cause ineffective. Without new antibiotics, more patients will die from previously treatable infections. However, a key issue is how […]